-
1Academic Journal
Συγγραφείς: O. N. Zuban, M. A. Prokopovich, R. M. Chotchaev, D. A. Vishnevskii, M. P. Korchagin, О. Н. Зубань, М. А. Прокопович, Р. М. Чотчаев, Д. А. Вишневский, М. П. Корчагин
Πηγή: Urology Herald; Том 13, № 4 (2025); 5-13 ; Вестник урологии; Том 13, № 4 (2025); 5-13 ; 2308-6424 ; 10.21886/2308-6424-2017-72-6
Θεματικοί όροι: качество жизни, subtotal bladder resection, enchanced recovery after surgery, ERAS, quality of life, субтотальная резекция мочевого пузыря, протокол ускоренного восстановления после хирургии
Περιγραφή αρχείου: application/pdf
Relation: https://www.urovest.ru/jour/article/view/1105/662; Фтизиатрия. Национальное руководство. Под ред. М.И. Перельмана. М.: ГЭОТАР-Медна; 2007.; Зубань О.Н., Комяков Б.К. Хирургическая коррекция малого мочевого пузыря. СПб: Стикс; 2011.; Melloul E., Hübner M., Scott M., Snowden C., Prentis J., Dejong C.H., Garden O.J., Farges O., Kokudo N., Vauthey J.N., Clavien P.A., Demartines N. Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations. World J Surg. 2016;40(10):2425-2440. DOI:10.1007/s00268-016-3700-1; Nelson G., Kalogera E., Dowdy S.C. Enhanced recovery pathways in gynecologic oncology. Gynecol Oncol. 2014;135(3):586-594. DOI:10.1016/j.ygyno.2014.10.006; Jahantabi E., Soleimanzadeh F., Salehi-Pourmehr H., Saadat M.Z., Nouri M., Hajebrahimi S. An adapted enhanced recovery protocol for adult augmentation cystoplasty in limited sources countries: A pilot clinical trial. Turk J Urol. 2021;47(6):509-517. DOI:10.5152/tud.2021.21108; Зубань О.Н., Чотчаев Р.М. Интестиноцистопластика при туберкулезном поражении мочевого пузыря. Экспериментальная и клиническая урология. 2022;15(4):115-121.; Воробьев В.А., Белобородов В.А., Тухиев А.Р. Ускоренное выздоровление. предоперационная подготовка и преабилитация. Экспериментальная и клиническая урология. 2023;16(1):10-17.; Wei C., Wan F., Zhao H., Ma J., Gao Z., Lin C. Application of enhanced recovery after surgery in patients undergoing radical cystectomy. J Int Med Res. 2018;46(12):5011-5018. DOI:10.1177/0300060518789035; Romagnoli D., Schiavina R., Bianchi L., Borghesi M., Chessa F., Mineo Bianchi F., Angiolini A., Casablanca C., Giampaoli M., Corsi P.,D'Agostino D., Brunocilla E., Porreca A. Is Fast Track protocol a safe tool to reduce hospitalization time after radical cystectomy with ileal urinary diversion? Initial results from a single high-volume centre. Arch Ital Urol Androl. 2020;91(4):230-236. DOI:10.4081/aiua.2019.4.230; Schulz G.B., Volz Y., Jokisch F., Casuscelli J., Eismann L., Pfitzinger P., Stief C.G., Schlenker B. Aktuelle Studienlage der Enhanced Recovery After Surgery (ERAS®) nach radikaler Zystektomie [Enhanced Recovery After Surgery (ERAS®) after radical cystectomy-current data]. Urologe A. 2021;60(2):162-168. (In German). DOI:10.1007/s00120-020-01435-y; Herbert G., Perry R., Andersen H.K., Atkinson C., Penfold C., Lewis S.J., Ness A.R., Thomas S. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications. Cochrane Database Syst Rev. 2019;7(7):CD004080. DOI:10.1002/14651858.CD004080.pub4; Fischer N.D., Epple S., Wittenmeier E., Betz U., Haferkamp A., Jäger W. Implementierung des ERAS®-Protokolls (Enhanced Recovery After Surgery) nach radikaler Zystektomie an der Universitätsmedizin Mainz [Implementation of Enhanced Recovery after Surgery (ERAS®) protocol in radical cystectomy at the University Medical Center Mainz]. Urologe A. 2021;60(2):169-177. (In German). DOI:10.1007/s00120-020-01430-3; Vukovic N., Dinic L. Enhanced Recovery After Surgery Protocols in Major Urologic Surgery. Front Med (Lausanne). 2018;5:93. DOI:10.3389/fmed.2018.00093; Lv Z., Cai Y., Jiang H., Yang C., Tang C., Xu H., Li Z., Fan B., Li Y. Impact of enhanced recovery after surgery or fast track surgery pathways in minimally invasive radical prostatectomy: a systematic review and meta-analysis. Transl Androl Urol. 2020;9(3):1037-1052. DOI:10.21037/tau-19-884; https://www.urovest.ru/jour/article/view/1105
-
2Academic Journal
Συγγραφείς: S. V. Popov, R. G. Huseynov, E. V. Pomeshkin, O. N. Scriabin, K. V. Sivak, V. V. Perepelitsa, T. A. Lelyavina, E. A. Malyshev, С. В. Попов, Р. Г. Гусейнов, Е. В. Помешкин, О. Н. Скрябин, К. В. Сивак, В. В. Перепелица, Т. А. Лелявина, Е. А. Малышев
Πηγή: Urology Herald; Том 12, № 3 (2024); 70-78 ; Вестник урологии; Том 12, № 3 (2024); 70-78 ; 2308-6424 ; 10.21886/2308-6424-2024-12-3
Θεματικοί όροι: мочевой пузырь, transurethral resection of the bladder, laser resection, recurrence, bladder, трансуретральная резекция мочевого пузыря, лазерная резекция, рецидив
Περιγραφή αρχείου: application/pdf
Relation: https://www.urovest.ru/jour/article/view/884/564; Гусниев М.А., Печникова В.В., Гущин М.Ю., Гусниев С.А., Гиоева З.В., Пшихачев А.М., Михалева Л.М. Анализ факторов риска рецидива немышечно-инвазивного рака мочевого пузыря после его комбинированного лечения. Медицинский вестник Северного Кавказа. 2022;17(3):264-268. DOI:10.14300/mnnc.2022.17064; Shore ND, Palou Redorta J, Robert G, Hutson TE, Cesari R, Hariharan S, Rodríguez Faba Ó, Briganti A, Steinberg GD. Non-muscle-invasive bladder cancer: An overview of potential new treatment options. Urol Oncol. 2021;39(10):642-663. DOI:10.1016/j.urolonc.2021.05.015; Иванов С.А., Заборский И.Н., Чайков В.С. Лечение немышечно-инвазивного рака мочевого пузыря высокого риска. Вестник урологии. 2017;5(2):42-49. DOI:10.21886/2308-6424-2017-5-2-42-49; Al Hussein Al Awamlh B, Chang SS. Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer. Curr Oncol Rep. 2023;25(2):83-91. DOI:10.1007/s11912-022-01350-9; Бабаевская Д.И., Базаркин А.К., Тараткин М.С., Еникеев Д.В. Новейшие достижения в трансуретральной резекции стенки мочевого пузыря с опухолью. Вестник урологии. 2022;10(1):96-103. DOI:10.21886/2308-6424-2022-10-1-96-103; Ивахно К.Ю., Важенин А.В., Карнаух П.А., Мисюкевич Н.Д. Мировой опыт применение тулиевого лазера в лечении мышечно-неинвазивного рака мочевого пузыря. Вестник Совета молодых учёных и специалистов Челябинской области. 2018;2(1):111-112. eLIBRARY ID: 35010553; EDN: XOXQBV; Li C, Gao L, Zhang J, Yang X, Liu C. The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Lasers Med Sci. 2020;35(5):1025-1034. DOI:10.1007/s10103-020-02972-w; Chen J, Zhao Y, Wang S, Jin X, Sun P, Zhang L, Wang M. Green-light laser en bloc resection for primary non-muscle-invasive bladder tumor versus transurethral electroresection: A prospective, nonrandomized two-center trial with 36-month follow-up. Lasers Surg Med. 2016;48(9):859-865. DOI:10.1002/lsm.22565; Xu Y, Guan W, Chen W, Xie C, Ouyang Y, Wu Y, Liu C. Comparing the treatment outcomes of potassium-titanyl-phosphate laser vaporization and transurethral electroresection for primary nonmuscle-invasive bladder cancer: A prospective, randomized study. Lasers Surg Med. 2015;47(4):306-311. DOI:10.1002/lsm.22342; Jin YH, Zeng XT, Liu TZ, Bai ZM, Dou ZL, Ding DG, Fan ZL, Han P, Huang YR, Huang X, Li M, Li XD, Li YN, Li XH, Liang CZ, Liu JM, Ma HS, Qi J, Shi JQ, Wang J, Wang DL, Wang ZP, Wang YY, Wang YB, Wei Q, Xia HB, Xing JC, Yan SY, Zhang XP, Zheng GY, Xing NZ, He DL, Wang XH; Chinese Urological Doctor Association (CUDA), Urological Association of Chinese Research Hospital Association (CRHA-UA), Uro-Health Promotive Association of China International Exchange, Promotive Association for Medical, Health Care (CPAM-UHPA). Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition). Mil Med Res. 2022;9(1):44. DOI:10.1186/s40779-022-00406-y; Musat MG, Kwon CS, Masters E, Sikirica S, Pijush DB, Forsythe A. Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR). Clinicoecon Outcomes Res. 2022;14:35-48. DOI:10.2147/CEOR.S341896; Liem EIML, Freund JE, Savci-Heijink CD, de la Rosette JJMCH, Kamphuis GM, Baard J, Liao JC, van Leeuwen TG, de Reijke TM, de Bruin DM. Validation of Confocal Laser Endomicroscopy Features of Bladder Cancer: The Next Step Towards Real-time Histologic Grading. Eur Urol Focus. 2020;6(1):81-87. DOI:10.1016/j.euf.2018.07.012; Poletajew S, Krajewski W, Gajewska D, Sondka-Migdalska J, Borowik M, Buraczyński P, Dzięgała M, Łykowski M, Przudzik M, Tukiendorf A, Woźniak R, Bar K, Jabłonowski Z, Roslan M, Słojewski M, Zdrojowy R, Radziszewski P, Dziobek K. Prediction of the risk of surgical complications in patients undergoing monopolar transurethral resection of bladder tumour - a prospective multicentre observational study. Arch Med Sci. 2019;16(4):863-870. DOI:10.5114/aoms.2019.88430; Kamadjou C, Kuitche J, Wadeu A, Mbassi A, Angwafo F. Transurethral Resection of Bladder Tumours: Results and Outcomes. Open Journal of Urology. 2022;12:342-356. DOI:10.4236/oju.2022.126033; Lonati C, Esperto F, Scarpa RM, Papalia R, Gómez Rivas J, Alvarez-Maestro M, Afferi L, Fankhauser CD, Mattei A, Colombo R, Montorsi F, Briganti A, Krajewski W, Carando R, Laukhtina E, Teo JY, Zamboni S, Simeone C, Moschini M; European Association of Urology - Young Academic Urologists (EAU-YA U): Urothelial Carcinoma Working Group; European Association of Urology - European Society of Resident Urologists (EAU-ESRU). Bladder perforation during transurethral resection of the bladder: a comprehensive algorithm for diagnosis, management and follow-up. Minerva Urol Nephrol. 2022;74(5):570-580. DOI:10.23736/S2724-6051.21.04436-0; Long G, Zhang Y, Sun G, Ouyang W, Liu Z, Li H. Safety and efficacy of thulium laser resection of bladder tumors versus transurethral resection of bladder tumors: a systematic review and meta-analysis. Lasers Med Sci. 2021;36(9):1807-1816. DOI:10.1007/s10103-021-03272-7; https://www.urovest.ru/jour/article/view/884
-
3Academic Journal
Συγγραφείς: M. D. Ter-Ovanesov, D. M. Yagudaev, A. A. Gritskevich, A. V. Umyarova, V. A. Bezhenar, М. Д. Тер-Ованесов, Д. М. Ягудаев, А. А. Грицкевич, А. В. Умярова, В. А. Беженар
Πηγή: Research and Practical Medicine Journal; Том 11, № 1 (2024); 70-77 ; Research'n Practical Medicine Journal; Том 11, № 1 (2024); 70-77 ; 2410-1893 ; 10.17709/2410-1893-2024-11-1
Θεματικοί όροι: муцинозная аденокарцинома урахуса, resection of the bladder, mucinous adenocarcinoma of urachus, резекция мочевого пузыря
Περιγραφή αρχείου: application/pdf
Relation: https://www.rpmj.ru/rpmj/article/view/916/613; Loizzo D, Pandolfo SD, Crocerossa F, Guruli G, Ferro M, Paul AK, et al. Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice. Eur Urol Open Sci. 2022 Mar 14;39:1–6. https://doi.org/10.1016/j.euros.2022.02.009; Bruins HM, Visser O, Ploeg M, Hulsbergen-van de Kaa CA, Kiemeney LA, Witjes JA. The clinical epidemiology of urachal carcinoma: results of a large, population based study. J Urol. 2012 Oct;188(4):1102–1107. https://doi.org/10.1016/j.juro.2012.06.020; Нюшко К. М., Алексеев Б. Я., Каприн А. Д. Клиническое наблюдение органосохраняющего хирургического лечения больного раком урахуса. Медицинский альманах. 2015;2(37):53–57.; Kim IK, Lee JY, Kwon JK, Park JJ, Cho KS, Ham WS, et al. Prognostic factors for urachal cancer: a bayesian model-averaging approach. Korean J Urol. 2014 Sep;55(9):574–580. https://doi.org/10.4111/kju.2014.55.9.574; Щедров Д. Н., Шорманов И. С., Котов С. В., Морозов Е. В. Диагностика и лечение заболеваний, обусловленных аномалиями облитерации урахуса у детей. М.: Издательство «Перо»; 2021, 107 с.; Claps M, Stellato M, Zattarin E, Mennitto A, Sepe P, Guadalupi V, et al. Current Understanding of Urachal Adenocarcinoma and Management Strategy. Curr Oncol Rep. 2020 Jan 27;22(1):9. https://doi.org/10.1007/s11912-020-0878-z; Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE. Malignant urachal lesions. J Urol. 1984 Jan;131(1):1–8. https://doi.org/10.1016/s0022-5347(17)50167-6; Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED, Zincke H. Urachal carcinoma: clinicopathologic features and longterm outcomes of an aggressive malignancy. Cancer. 2006 Aug 15;107(4):712–720. https://doi.org/10.1002/cncr.22060; Pinthus JH, Haddad R, Trachtenberg J, Holowaty E, Bowler J, Herzenberg AM, et al. Population based survival data on urachal tumors. J Urol. 2006 Jun;175(6):2042–2047; discussion 2047. https://doi.org/10.1016/s0022-5347(06)00263-1; Shao G, Xu C, Liu J, Li X, Li L, Li X, et al. Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma. Urol Int. 2022;106(2):199–208. https://doi.org/10.1159/000518028; Szarvas T, Módos O, Niedworok C, Reis H, Szendröi A, Szász MA, Nyirády P. Clinical, prognostic, and therapeutic aspects of urachal carcinoma-A comprehensive review with meta-analysis of 1,010 cases. Urol Oncol. 2016 Sep;34(9):388–398. https://doi.org/10.1016/j.urolonc.2016.04.012; Helsby R. Ruptured infected urachal cyst. Br Med J. 1955 Sep 3;2(4939):603. https://doi.org/10.1136/bmj.2.4939.603; Dhillon J, Liang Y, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B, Guo CC. Urachal carcinoma: a pathologic and clinical study of 46 cases. Hum Pathol. 2015 Dec;46(12):1808–1814. https://doi.org/10.1016/j.humpath.2015.07.021; Cinar NB, Yilmaz H, Avci IE, Cakmak K, Teke K, Dillioglugil O. Reporting perioperative complications of radical cystectomy: the influence of using standard methodology based on ICARUS and EAU quality criteria. World J Surg Oncol. 2023 Feb 23;21(1):58. https://doi.org/10.1186/s12957-023-02943-9; Mayr R, Fritsche HM, Pycha A, Pycha A. Radical cystectomy and the implications of comorbidity. Expert Rev Anticancer Ther. 2014 Mar;14(3):289–295. https://doi.org/10.1586/14737140.2014.868775; Duan F, Zhai W, Zhang B, Guo S. Urachal carcinoma: Impact of recurrence pattern and lymphadenectomy on long-term outcomes. Cancer Med. 2020 Jun;9(12):4166–4174. https://doi.org/10.1002/cam4.3059; Нюшко К. М., Алексеев Б. Я., Калпинский А. С., Каприн А. Д. Рак урахуса. Онкология. Журнал им. П. А. Герцена. 2015;4(3):43–47.; Кунафина Р. И., Сакаева Д. Д., Урманцев М. Ф., Сулейманова Р. Р. Клинический случай применения комбинации паклитаксела и карбоплатина в терапии метастатической опухоли урахуса. Фарматека. 2020;27(11):73–76. https://doi.org/10.18565/pharmateca.2020.11.73-76; https://www.rpmj.ru/rpmj/article/view/916
-
4
-
5Academic Journal
Συγγραφείς: Yakovlev, P. H., Kliushyn, D. A.
Πηγή: Zaporozhye Medical Journal; Vol. 22 No. 5 (2020) ; Запорожский медицинский журнал; Том 22 № 5 (2020) ; Запорізький медичний журнал; Том 22 № 5 (2020) ; 2310-1210 ; 2306-4145
Θεματικοί όροι: undifferentiated bladder cancer, partial cystectomy, recurrence, salvage cystectomy, survival, radiotherapy, недиференційований рак сечового міхура, резекція сечового міхура, рятівна цистектомія, рецидив, виживаність, променева терапія, недифференцированный рак мочевого пузыря, резекция мочевого пузыря, спасительная цистэктомия, выживаемость, лучевая терапия
Περιγραφή αρχείου: application/pdf
Relation: http://zmj.zsmu.edu.ua/article/view/214743/214897; http://zmj.zsmu.edu.ua/article/view/214743
Διαθεσιμότητα: http://zmj.zsmu.edu.ua/article/view/214743
-
6Academic Journal
Συγγραφείς: I. N. Zaborskii, K. N. Safiullin, O. B. Karyakin, S. A. Ivanov, V. S. Chaikov, I. O. Dementev, A. V. Sidorin, G. N. Grishin, A. N. Yurchenko, И. Н. Заборский, К. Н. Сафиуллин, О. Б. Карякин, С. А. Иванов, В. С. Чайков, И. О. Дементьев, А. В. Сидорин, Г. Н. Гришин, А. Н. Юрченко
Πηγή: Research and Practical Medicine Journal; Том 7, № 2 (2020); 129-143 ; Research'n Practical Medicine Journal; Том 7, № 2 (2020); 129-143 ; 2410-1893 ; 10.17709/2409-2231-2020-7-2
Θεματικοί όροι: трансуретральная резекция мочевого пузыря, diagnosis, cystoscopy, photodynamic diagnosis, narrow-spectrum diagnosis, transurethral resection of the bladder, диагностика, цистоскопия, фотодинамическая диагностика, узкоспектровая диагностика
Περιγραφή αρχείου: application/pdf
Relation: https://www.rpmj.ru/rpmj/article/view/546/365; Состояние онкологической помощи населению России в 2018 году под редакцией А.Д. Каприна, В.В. Старинского, Г.В. Петровой, 2019.; Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al., editors. AJCC Cancer Staging Manual, 8th ed. Springer International Publishing: New York; 2017. Available from: https://www.springer.com/gp/book/9783319406176; Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) — 2019 Update. Eur Urol. 2019 Nov; 76(5): 639–657. https://doi.org/10.1016/j.eururo.2019.08.016; Алексеев Б. Я., Андронов А. С., Атдуев В. А., Байков Н. А., Важенин А. В., Васильев О.Н. и др. Рак мочевого пузыря (классика и новации). Медфорум. Монография. Москва, 2017, 262 с.; Иванов С.А., Заборский И.Н., Чайков В.С. Лечение немышечно-инвазивного рака мочевого пузыря высокого риска. Вестник Урологии. 2017; 5(2): 42–49. https://doi.org/10.21886/2308–6424–2017–5-2–42–49; Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol. 2017; 71(3): 447–461. https://doi.org/10.1016/j.eururo.2016.05.041; Geavlete B, Multescu R, Georgescu D, Stanescu F, Jecu M, Geavlete P. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors-results of a prospective, randomized comparison to the standard approach. Urology. 2012 Apr; 79(4): 846–851. https://doi.org/10.1016/j.urology.2011.08.081; Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, et al. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014 Oct; 11(10): 589–596. https://doi.org/10.1038/nrurol.2014.245; Malmström P‐U, Agrawal S, Bläckberg M, Boström PJ, Malavaud B, Zaak D, et al. Non-muscle-invasive bladder cancer: a vision for the future. Scand J Urol. 2017 Apr; 51(2): 87–94. https://doi.org/10.1080/21681805.2017.1283359; Isfoss BL. The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard. BJU Int. 2011 Dec; 108(11): 1703–1707. https://doi.org/10.1111/j.1464–410X.2011.10485.x; Лоран О.Б., Серегин А.В., Дадашев Э.О., Бабаев А.Б., Лощенов В.Б. Фотодинамическая диагностика отечественной флуоресцентной видеосистемой неинвазивного рака мочевого пузыря. Consilium Medicum. 2018; 20(7): 37–40. https://doi.org/10.26442/2075–1753_2018.7.37–40; Burger M, Grossman HB, Droller M, Schmidbauer J, Hermann G, Drăgoescu O, et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol. 2013 Nov; 64(5): 846–854. https://doi.org/10.1016/j.eururo.2013.03.059; Kamat A, Cookson M, Witjes JA, Stenzl A, Grossman HB. TheImpact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer — A New Analysis. Bladder Cancer. 2016 Apr 27; 2(2): 273–278. https://doi.org/10.3233/BLC-160048; Daneshmand S, Bazargani ST, Bivalacqua TJ, Holzbeierlein JM, Willard B, Taylor JM, et al. Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry. Urol Oncol. 2018; 36(8): 361.e1–361.e6. https://doi.org/10.1016/j.urolonc.2018.04.013; Gallagher KM, Gray K, Anderson CH, Lee H, Stewart S, Donat R, et al. “Real-life experience”: recurrence rate at 3 years with Hexvix® photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC-a prospective controlled study. World J Urol. 2017 Dec; 35(12): 1871–1877. https:// doi.org/10.1007/s00345–017–2077–6; Bach T, Bastian PJ, Blana A, Kaminsky A, Keller S, Knoll T, et al. Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III. World J Urol. 2017 May; 35(5): 737–744. https://doi.org/10.1007/s00345–016–1925–0; Pagliarulo V, Alba S, Gallone MF, Di Stasi S, Cormio L, Petitti T, et al. Diagnostic Accuracy of Hexaminolevulinate in a Cohort of Patients Undergoing Radical Cystectomy. J Endourol. 2017; 31(4): 405–411. https://doi.org/10.1089/end.2016.0804; Drăgoescu PO, Tudorache Ş, Drocaş AI, Mitroi G, Pănuş A, Drăgoescu NAM, et al. Improved diagnosis and long-term recurrence rate reduction for non-muscle-invasive bladder cancer patients undergoing fluorescent hexylaminolevulinate photodynamic diagnosis. Rom J Morphol Embryol. 2017; 58(4): 1279–1283.; Lykke MR, Nielsen TK, Ebbensgaard NA, Zieger K. Reducing recurrence in non-muscle-invasive bladder cancer using photodynamic diagnosis and immediate post-transurethral resection of the bladder chemoprophylaxis. Scand J Urol. 2015 Jun; 49(3): 230–236. https://doi.org/10.3109/21681805.2015.1019562; Kata SG, Zreik A, Ahmad S, Chłosta P, Aboumarzouk O. Concurrent bladder cancer in patients undergoing photodynamic diagnostic ureterorenoscopy: how many lesions do we miss under white light cystoscopy? Cent European J Urol. 2016; 69(4): 334–340. https://doi.org/10.5173/ceju.2016.896; Kim SB, Yoon SG, Tae J, Kim JY, Shim JS, Kang SG, et al. Detection and recurrence rate of transurethral resection of bladder tumors by narrow-band imaging: Prospective, randomized comparison with white light cystoscopy. Investig Clin Urol. 2018; 59(2): 98–105. https://doi.org/10.4111/icu.2018.59.2.98; Drejer D, Béji S, Oezeke R, Nielsen AM, Høyer S, Bjerklund Johansen TE, et al. Comparison of White Light, Photodynamic Diagnosis, and Narrow-band Imaging in Detection of Carcinoma In Situ or Flat Dysplasia at Transurethral Resection of the Bladder: the DaBlaCa 8 Study. Urology. 2017; 102: 138–142. https://doi.org/10.1016/j.urology.2016.11.032; Naito S, Algaba F, Babjuk M, Bryan RT, Sun Y H, Valiquette L, et al. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1 year Results. Eur Urol. 2016; 70(3): 506–515. https://doi.org/10.1016/j.eururo.2016.03.053; Xiong Y, Li J, Ma S, Ge J, Zhou L, Li D, et al. A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer. PLoS ONE. 2017; 12(2): e0170819. https://doi.org/10.1371/journal.pone.0170819; Bryan RT, Shah ZH, Collins SI, Wallace DMA. Narrow-bandimaging flexible cystoscopy: a new user’s experience. J Endourol. 2010 Aug; 24(8): 1339–1343. https://doi.org/10.1089/end.2009.0598; Kang W, Cui Z, Chen Q, Zhang D, Zhang H, Jin X. Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis. Oncotarget. 2017 Apr 4; 8(14): 23880. https://doi.org/10.18632/oncotarget.13054; Geavlete BF, Brînzea A, ChecheriŢă IA, Zurac SA, GeorgescuDA, Bastian AE, et al. Carcinoma in situ of the urinary bladder — from pathology to narrow band imaging. Rom J Morphol Embryol. 2015; 56(3): 1069–1076.; Lee JY, Cho KS, Kang DH, Jung HD, Kwon JK, Oh CK, et al. A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5 aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging. BMC Cancer. 2015 Aug 1; 15: 566. https://doi.org/10.1186/s12885–015–1571–8; Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science. 1991 Nov 22; 254(5035): 1178–1181. https://doi.org/10.1126/science.1957169; Huang J, Ma X, Zhang L, Jia H, Wang F. Diagnostic accuracy of optical coherence tomography in bladder cancer patients: A systematic review and meta-analysis. Mol Clin Oncol. 2018 Apr; 8(4): 609–612. https://doi.org/10.3892/mco.2018.1566; Xiong YQ, Tan J, Liu Y M, Li Y Z, You F F, Zhang M Y, et al. Diagnostic accuracy of optical coherence tomography for bladder cancer: A systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2019 Sep; 27: 298–304. https://doi.org/10.1016/j.pdpdt.2019.06.006; Lerner SP, Goh A. Novel endoscopic diagnosis for bladder cancer. Cancer. 2015 Jan 15; 121(2): 169–178. https://doi.org/10.1002/cncr.28905; Chang TC, Liu J J, Hsiao ST, Pan Y, Mach KE, Leppert JT, et al. Interobserver agreement of confocal laser endomicroscopy for bladder cancer. J Endourol. 2013 May; 27(5): 598–603. https://doi.org/10.1089/end.2012.0549; Liem EI, Freund JE, Baard J, de Bruin DM, Laguna Pes MP, Savci-Heijink CD, et al. Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies. JMIR Res Protoc. 2018 Feb 7; 7(2): e34. https://doi.org/10.2196/resprot.8862; Rao AR, Hanchanale V, Javle P, Karim O, Motiwala H. Spectroscopic view of life and work of the Nobel Laureate Sir C.V. Raman. J Endourol. 2007 Jan; 21(1): 8–11. https://doi.org/10.1089/end.2006.9998; Schäfauer C, Ettori D, Rouprêt M, Phé V, Tualle J M, Tinet E, et al. Detection of bladder urothelial carcinoma using in vivo noncontact, ultraviolet excited autofluorescence measurements converted into simple color coded images: a feasibility study. J Urol. 2013 Jul; 190(1): 271–277. https://doi.org/10.1016/j.juro.2013.01.100; Zipfel WR, Williams RM, Webb WW. Nonlinear magic: multiphoton microscopy in the biosciences. Nat Biotechnol. 2003 Nov; 21(11): 1369–1377. https://doi.org/10.1038/nbt899; Jain M, Robinson BD, Scherr DS, Sterling J, Lee M–M, Wysock J, et al. Multiphoton microscopy in the evaluation of human bladder biopsies. Arch Pathol Lab Med. 2012 May; 136(5): 517–526. https://doi.org/10.5858/arpa.2011–0147-OA; Tewari AK, Shevchuk MM, Sterling J, Grover S, Herman M, Yadav R, et al. Multiphoton microscopy for structure identification in human prostate and periprostatic tissue: implications in prostate cancer surgery. BJU Int. 2011 Nov; 108(9): 1421–1429. https://doi.org/10.1111/j.1464–410X.2011.10169.x; Rivera DR, Brown CM, Ouzounov DG, Pavlova I, Kobat D, Webb WW, et al. Compact and flexible raster scanning multiphoton endoscope capable of imaging unstained tissue. Proc Natl Acad Sci USA. 2011 Oct 25; 108(43): 17598–17603. https://doi.org/10.1073/pnas.1114746108; Seibel EJ, Brentnall TA, Dominitz JA. New endoscopic and cytologic tools for cancer surveillance in the digestive tract. Gastrointest Endosc Clin N Am. 2009 Apr; 19(2): 299–307. https://doi.org/10.1016/j.giec.2009.02.002; Seibel EJ, Brown CM, Dominitz JA, Kimmey MB. Scanning single fiber endoscopy: a new platform technology for integrated laser imaging, diagnosis, and future therapies. Gastrointest Endosc Clin N Am. 2008 Jul; 18(3): 467–478, viii. https://doi.org/10.1016/j.giec.2008.05.001; Yoon WJ, Park S, Reinhall PG, Seibel EJ. Development of an Automated Steering Mechanism for Bladder Urothelium Surveillance. J Med Device. 2009 Mar 1; 3(1): 11004. https://doi.org/10.1115/1.3054381; https://www.rpmj.ru/rpmj/article/view/546
-
7Academic Journal
Συγγραφείς: F. R. Asfandiyarov, V. Yu. Startsev, A. Yu. Kolmakov, Ф. Р. Асфандияров, В. Ю. Старцев, А. Ю. Колмаков
Πηγή: Urology Herald; Том 6, № 3 (2018); 5-11 ; Вестник урологии; Том 6, № 3 (2018); 5-11 ; 2308-6424 ; 10.21886/2308-6424-2018-6-3
Θεματικοί όροι: трансуретральная резекция мочевого пузыря, Schistosoma mansoni, urogenital schistosomiasis, cytological examination of urine sediment, cystoscopy, transurethral resection of the bladder, урогенитальный шистосомоз, цитологическое исследование осадка мочи, цистоскопия
Περιγραφή αρχείου: application/pdf
Relation: https://www.urovest.ru/jour/article/view/213/181; International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr. Eval. Carcinog. Risks Hum.1994;61:45-100.; World Health Organiza on. Fact sheet N.115: Schistosomiasis. Электронный ресурс. WHO. Электрон, текстовые дан. – Режим доступа: h p://www.who.int/mediacentre/factsheets/fs115/en/. Accessed October 2017; Брико Н.И., Покровский В.И. Глобализация и эпидемический процесс. Эпидемиология и инфекционные болезни. 2010;4:6.; Maestro MA, Gonzalez ER, Garcia PD et al. Bladder schistosomiasis: case report and bibliographic review. Arch. Esp. Urol. 2010;63(7):554-558. PMID: 20945592; Boissier J, Grech-Angelini S, Webster BL et al. Outbreak of urogenital schistosomiasis in Corsica (France): an epidemiological case study. Lancet Infect. Dis. 2016;16(8):971-979. DOI:10.1016/S1473-3099(16)00175-4; Бронштейн А.М., Малышев Н.А., Жаров С.Н. Острый мочеполовой шистосомоз у туриста, посетившего Уганду и Кению: описание случая и обзор литературы. Эпидемиология и инфекционные болезни. 2012;5:47-50.; Катаханова Л.Л., Савин В.А., Исаева Я.В, Болотская Т.Г. Случай мочеполового шистосомоза у ребенка 10 лет. Вестник Сургута. 2013;1(15):59-61.; Шахулина Л.Р., Валшин Д. А., Хунафина Д.Х., Галиева А.Т. Мочеполовой шистосомоз, клинический случай. Инфекционные болезни. 2017;15(1):317.; Brito de PA, Kazura JW, Mahmoud AA. Host granulomatous response in Schistosomiasis mansoni An body and cellmediated damage of parasite eggs in vitro. J. Clin. Invest. 1984;74(5):1715–1723. DOI:10.1172/JCI111589; Savioli L, Renganathan E, Montresor A et al. Division of control of Tropical Diseases, Schistomiasis and Intes nal Parasites unit, World Health Organiza on. Control of schistosomiasis—a global picture. Parasitol. Today.1997;13:444–448; Alwan MH, Al-Shukri S, Lafi MO. Bilharzial Anuria. Bahrain Medical Bulle n. 1984;6(3):78-80.; Shokeir AA. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int. 2004;93:216–220. PMID: 14690486; Bichler КH, Savatovsky I, Members of the Urinary Tract Infec on (UTI) Working Group of the Guidelines Offi ce of the European Associa on of Urology (EAU): Naber KG, Bischop MC, Bjerklund-Johansen TE, Bo o H, Cek M, Grabe M, Lobel B, Redorta JP, Tenke P. EAU Guidelines for the Management of Urogenital Schistosomiasis. Eur Urol. 2006. 49(6):9981003. DOI:10.1016/j.eururo.2006.02.022; Gen le JM. Schistosome related cancers: a possible role for genotoxins. Environ. Mutagen.1985;7:775–785. DOI:10.1002/em.2860070514; https://www.urovest.ru/jour/article/view/213
-
8Academic Journal
Συγγραφείς: K. O. Tsedenova, M. I. Komarov, A. D. Panakhov, V. B. Matveev, D. A. Sergeev, A. A. Beshtoev, К. О. Цеденова, М. И. Комаров, А. Д. Панахов, В. Б. Матвеев, Д. А. Сергеев, А. А. Бештоев
Πηγή: Cancer Urology; Том 14, № 4 (2018); 103-109 ; Онкоурология; Том 14, № 4 (2018); 103-109 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2018-14-4
Θεματικοί όροι: трансуретральная резекция мочевого пузыря, small-cell carcinoma of the bladder, neuroendocrine cancer, neurourothelial carcinoma of the bladder, radical cystectomy, neoadjuvant chemotherapy, transurethral resection of the bladder, мелкоклеточный рак мочевого пузыря, нейроэндокринный рак, неуротелиальный рак мочевого пузыря, радикальная цистэктомия, неоадъювантная химиотерапия
Περιγραφή αρχείου: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/816/813; Ferlay J. GLOBOCAN 2012 v1.0: Esti-mated cancer incidence, mortality and prevalence worldwide in 2012. 2013. Available at: http://globocan.iarc.fr/Default.aspx.; Злокачественные новообразования в России в 2016 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2018. 250 с.; Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017;67(1):7—30. DOI:10.3322/caac.21387. PMID: 28055103.; WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th edn. Lyon, France, 2016.; Kapur P., Lotan Y., King E. et al. Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers. Am J Clin Pathol 2011;135(6):822—30. DOI:10.1309/AJCP76KUVOTBKQRY. PMID: 21571954.; Ploeg M. Clinical epidemiology of nonurothelial bladder cancer: analyses of the Netherlands Cancer Registry. J Urol 2010;183:915.; Beltran A.L., Cheng L., Montironi R. et al. Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder. Virchows Arch 2014;465(2):199—205. DOI:10.1007/s00428-014-1601-y. PMID: 24878757.; Mukesh M., Cook N., Hollingdale A.E. et al. Small cell carcinoma of the urinary bladder: a 15-year retrospective review of treatment and survival in the Anglian Cancer Network. BJU Int 2009;103(6):747— 52. DOI:10.1111/j.1464-410X.2008.08241.x. PMID: 19076139.; John Hopkins Department of Pathology. Available at: http://pathologyjhu.edu/bladdercancer.; Walther PJ. Adjuvant/neoadjuvant etoposide/cisplatin and cystectomy for management of invasive small cell carcinoma. J Urol 2002;167(4):285. [Abstract 1124].; Trias I., Algaba F., Condom E. et al. Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. Eur Urol 2001;39(1): 85—90. DOI:10.1159/000052417. PMID: 11173944.; Grignon D.J. Neoplasms of the urinary bladder. In: Urologic surgical pathology. Eds.: D.G. Bostwick, J.N. Eble. St. Louis (MO): Mosby-Year Book, Inc, 1997. Pp. 216—305.; Blomjous C.E., Vos W., De Voogt H.J. et al. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer 1989;64(6):1347—57. PMID: 2548704.; Helpap B. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract. Cancer 2002;95(7):1415—20. DOI:10.1002/cncr.10840. PMID: 12237909.; Holmang S., Borghede G., Johansson S.L. Primary small cell carcinoma of the bladder: a report pf 25 cases. J Urol 1995;153(6):1820—2. PMID: 7752326.; Rogers C.G., Palapattu G.S., Shariat S.F. et al. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J Urol 2006;175(6):2048—53. DOI:10.1016/S0022-5347(06)00317-X. PMID: 16697800.; Koay E.J., Teh B.S., Paulino A.C. Butler E.B. Treatment trends and outcomes of small-cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 2012;83(1):64—70. DOI:10.1016/j.ijrobp.2011.05.039. PMID: 22019246.; Bryant C.M., Dang L.H., Stechmiller B.K. et al. Treatment of small cell carcinoma of the bladder with chemotherapy and radiation after transurethral resection of a bladder tumor. Am J Clin Oncol 2016;39(1):69—75. DOI:10.1097/COC.0000000000000027. PMID: 24517956.; Fischer-Valuck B.W., Rao Y.J., Henke L.E. et al. Treatment patterns and survival outcomes for patients with small cell carcinoma of the bladder. Eur Urol Focus 2017. DOI:10.1016/j.euf.2017.09.001. PMID: 28919521.; Schreiber D., Rineer J., Weiss J. et al. Characterization and outcomes of small cell carcinoma of the bladder using the Surveillance, epidemiology, and end results database. Am J Clin Oncol 2013;36(2):126— 31. DOI:10.1097/COC.0b013e3182438c71. PMID: 22391430.; Lohrisch C., Murray N., Pickles T., Sullivan L. Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation. Cancer 1999;86(11):2346—52. PMID: 10590377.; Bex A., Nieuwenhuijzen J.A., Kerst M. et al. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology 2005;65(2):295—9. DOI:10.1016/j.urology.2004.09.049. PMID: 15708041.; Pasquier D., Barney B., Sundar S. et al. Small cell carcinoma of the urinary bladder: a retrospective, multicenter rare cancer network study of 107 patients. Int J Radiat Oncol Biol Phys 2015;92(4):904—10. DOI:10.1016/j.ijrobp.2015.03.019. PMID: 26104942.; Siefker-Radtke A.O., Kamat A.M., Grossman H.B. et al. Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. J Clin Oncol DOI:10.1200/JC0.2008.19.0256. PMID: 19414678.; Lynch S.P., Shen Y., Kamat A. et al. Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol201;64(2):307—13. DOI:10.1016/j.eururo.2012.04.020. PMID: 22564397.; https://oncourology.abvpress.ru/oncur/article/view/816
-
9Academic Journal
Συγγραφείς: N. I. Sorokin, D. V. Enikeev, A. M. Dymov, D. G. Tsarichenko, D. A. Kislyakov, G. Yu. Gololobov, L. O. Severgina, L. M. Rapoport, Н. И. Сорокин, Д. В. Еникеев, А. М. Дымов, Д. Г. Цариченко, Д. А. Кисляков, Г. Ю. Гололобов, Л. О. Севергина, Л. М. Рапопорт
Πηγή: Cancer Urology; Том 14, № 1 (2018); 144-151 ; Онкоурология; Том 14, № 1 (2018); 144-151 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2018-14-1
Θεματικοί όροι: «Уролаз», urothelial carcinoma, transurethral resection of bladder tumor, thulium laser, en bloc resection, “Urolaz”, уротелиальная карцинома, трансуретральная резекция мочевого пузыря, тулиевый лазер, резекция единым блоком
Περιγραφή αρχείου: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/791/744; Antoni S., Ferlay J., Soerjomataram I. et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 2017;71(1):96–108. DOI: http://dx.doi.org/10.1016/j.eururo.2016.06.010. PMID: 27370177.; Каприн А.Д., Аполихин О.И., Сивков А.В. и др. Анализ уронефрологической заболеваемости и смертности в Российской Федерации за 2003–2013 гг. Экспериментальная и клиническая урология 2015;(2):4–13.; Jemal A., Bray F., Center M.M. et al. Global cancer statistics. CA Cancer J Clin 2011;61(2):69–90. DOI: https://doi.org/10.3322/caac.20107. PMID: 21296855.; Ridge C.A., Pua B.B., Madoff D.C. Epidemiology and staging of renal cell carcinoma. Semin Intervent Radiol 2014;31(1):3–8. DOI: https://doi.org/10.1055/s-0033-1363837. PMID: 24596434.; Tyson M.D., Lee D., Clark P. New developments in the management of nonmuscle invasive bladder cancer. Curr Opin Oncol 2017;29(3):179–83. DOI:10.1097/cco.0000000000000362. PMID: 28282341.; EAU Guidelines on non-muscle-invasive bladder cancer (Ta, T1 and CIS). European Association of Urology. Guidelines 2017. Pp. 4–40.; Мартов А.Г., Ергаков Д.В., Байков Н.А. и др. Трансуретральное удаление опухолей мочевого пузыря единым блоком. Онкоурология 2015;(1):41–9. DOI:10.17650/1726-97762015-1-41-49.; Bryan R.T., Collins S.I., Daykin M.C. et al. Mechanisms of recurrence of Ta/T1 bladder cancer. Ann R Coll Surg Engl 2010;92(6):519–24. DOI:10.1308/003588410x12664192076935. PMID: 20522307.; Kamat A.M., Bağcıoğlu M., Huri E. What is new in non-muscle-invasive bladder cancer in 2016. Turk J Urol 2017;43(1):9–13. DOI:10.5152/tud.2017.60376. PMID: 28270945.; Grimm M.O., Steinhoff C., Simon X. et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003;170(2 Pt 1):433–7. DOI:10.1097/01.ju.0000070437.14275.e0. PMID: 12853793.; Staehler G., Schmiedt E., Hofstetter A. Destruction of bladder neoplasms by means of transurethral neodym-YAGlaser coagulation. Helv Chir Acta 1978;45(3):307–11. PMID: 568126.; Kawada T., Ebihara K., Suzuki T. et al. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol 1997;157(6):2225–6. PMID: 9146621.; Kramer M.W., Rassweiler J.J., Klein J. et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 2015;33(12):1937–43. DOI:10.1007/s00345-015-1568-6. PMID: 25910478.; EAU Guidelines on lasers and technologies. European Association of Urology. Guidelines 2016. Pp. 6–55.; Babjuk M., Böhle A., Burger M. et al. EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol 2017;71(3):447–61. DOI:10.1016/j.eururo.2016.05.041. PMID: 27324428.; Wu Y.P., Lin T.T., Chen S.H. et al. Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: a meta-analysis. Medicine (Baltimore) 2016;95(45):e5372. DOI:10.1097/MD.0000000000005372. PMID: 27828864.; https://oncourology.abvpress.ru/oncur/article/view/791
-
10Academic Journal
Συγγραφείς: M. M. Ulyanin, G. Т. Basiashvili, R. Sh. Khasanov, I. G. Gataullin, M. V. Burmistrov, G. R. Khayrullina, M. Ю. Ульянин, Г. Т. Басиашвили, Р. Ш. Хасанов, И. Г. Гатауллин, М. В. Бурмистров, Г. Р. Хайруллина
Πηγή: Cancer Urology; Том 11, № 4 (2015); 42-50 ; Онкоурология; Том 11, № 4 (2015); 42-50 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2015-11-4
Θεματικοί όροι: T1c, superficial bladder cancer, transurethral resection of bladder, transurethral resection of bladder en block, recurrence of bladder cancer, complications after transurethral resection, proper muscularis mucosa, T1a, T1b, поверхностный рак мочевого пузыря, трансуретральная резекция мочевого пузыря, трансуретральная резекция мочевого пузыря единым блоком, рецидив рака мочевого пузыря, осложнения после трансуретральной резекции, собственная мышечная пластинка слизистой оболочки, стадии T1a
Περιγραφή αρχείου: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/473/489; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/473/111; Состояние онкологической помощи населению России в 2012 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2013. [Incidence of malignant neoplasms in Russia in 2012. Eds. by: А.D. Kaprin, V.V. Starinskiy, Moscow, 2013. (In Russ.)].; Kausch von Schmeling I. Diagnosis of and therapy for non-muscle-invasive bladder cancer – state of the art. Aktuelle Urol 2010;41(5):307–15.; Sylvester R.J., van der Meijden A.P., Oosterlinck W. Predicting recurrence and progression in individual patients with stage Та T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466–77.; Hu Z., Mudaliar K., Quek M.L. et al. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence. Ann Diagn Pathol 2014;18(2):49—52.; Bobiński J., Lipiński M. EORTC risk tables–a new diagnostic tool in urology. Pol Merkur Lekarski 2009;27: 524–8.; Zehnder P., Thalmann G.N. Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer. Curr Opin Urol 2013;23(5):423–8.; Hermann G.G., Horn T., Steven K. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer. J Urol 1998;159(1):91–4.; Platz C.E., Cohen M.B., Jones M.P. et al. Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol 1996;9:1035–9.; Cheng L., Weaver A.L., Neumann R.M. et al. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: a new proposal. Cancer 1999;86:1035–43.; Angulo J.C., Lopez J.I., Grignon D.J., Sanchezhapado M. Muscularis mucosa differentiates 2 populations with different prognosis in stage T1 bladder-cancer. Urology 1995;45:47–53.; Holmang S., Hedelin H., Anderstrom C. et al. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol 1997;157:800–4.; Orsola A., Trias I., Raventos C.X. et al. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol 2005;48(2):231–8.; Rouprêt M., Seisen T., Compérat E. et al. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladdercarcinoma: French national multicenter study with central pathology review. J Urol 2013;189(6):2069–76.; Epstein J.I., Amin M.B., Reuter V.R., Mostofi F.K. The world health organization/ international society of urological patology consensus classification of urotelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22(12): 1435–48.; KawadT., Ebihara K, Suzuki T. et al. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol 1997;157(6):2225–6.; Naselli A., Introini C. En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm. BJU Int 2012;109: 960–3.; Upadhyay R., Kapoor R., Srivastava A. et al. Does En-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen? Indian J Urol 2012;28(3):275–9.; Muto G., Collura D., Giacobbe A. et al. Thulium: yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages. Urology 2014; 83(4):851–5.; Lodde M., Lusuardi L., Palermo S. et al. En bloc transurethral resection of bladder tumors: use and limits. Urology 2003;62(6): 1089–91.; Мартов А.Г., Ергаков Д.В., Байков Н.А. и др. Трансуретральное удаление опухолей мочевого пузыря единым блоком. Онкоурология 2015;11(2):41–50. [Martov A.G., Ergakov D.V., Baukov N.A. et al. Transurethral en bloc resection of bladder tumors. Onkourologiya = Oncourologiya 2015;11(2):41–50. (In Russ.].; Rodríguez-Alonso A., Pita-Fernández S., González-Carreró J., Nogueira-March J.L. Multivariate analysis of recurrence and progression in stage T1 transitional-cell carcinoma of the bladder. Prognostic value of p53 and Ki-67. Actas Urol Esp 2003;27(2):132–41.; https://oncourology.abvpress.ru/oncur/article/view/473
-
11Academic Journal
Συγγραφείς: A. G. Martov, D. V. Ergakov, N. A. Baykov, V. M. Pominalnaya, I. A. Solomatnikov, А. Г. Мартов, Д. В. Ергаков, Н. А. Байков, В. М. Поминальная, И. А. Соломатников
Πηγή: Cancer Urology; Том 11, № 1 (2015); 41-49 ; Онкоурология; Том 11, № 1 (2015); 41-49 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2015-11-1
Θεματικοί όροι: in situ bladder cancer, noninvasive bladder cancer, transurethral resection of the bladder, holmium resection of the bladder, laser resection of the bladder, en bloc endoscopic resection of the bladder, en bloc techniques, recurrent bladde, неинвазивный рак мочевого пузыря, трансуретральная резекция мочевого пузыря, гольмиевая резекция мочевого пузыря, лазерная резекция мочевого пузыря, эндоскопическая резекция мочевого пузыря единым блоком, техника единого блока
Περιγραφή αρχείου: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/416/426; Grasso M. Bladder cancer: a major public health issue. Eur Urol Suppl 2008;7:510–15.; Saito S. Transurethral en bloc resection of bladder tumors. J Urol 2001;166:2148–50.; Мартов А.Г., Ергаков Д.В., Андронов А.С. Рецидивирование мышечно-неинвазивного рака мочевого пузыря: возможные эндоскопические пути решения проблемы. Онкоурология 2010;1:6–14. [Martov A.G., Ergakov D.V., Andronov A.S. Recurrent nonmuscle invasive bladder cancer: possible endoscopic modes to solve the problem. Onkourologiya = Oncourology 2010;1:6–14 (In Russ.)].; Мартов А.Г., Андронов А.С., Ергаков Д.В., Дутов С.В. NBI и SPIES диагностика папиллярных опухолей верхних мочевых путей. 1 Интернациональный и 4 Российский конгресс по эндоурологии и новым технологиям. Батуми, 2014. С. 104–106 [Martov A.G., Andronov A.S., Ergakov D.V., Dutov S.V. NBI and SPIES diagnosis of papillary tumors of the upper urinary tract. I International and IV Russian Congress on endourology and new technologies. Batumi, 2014. P.104–106 (In Russ.)].; Brausi M., Collette L., Kurth K. et al. Variability in the recurrence rate at first followup cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol 2002;41:523–31.; Sylvester R.J., Oosterlinck W., van der Meijden A.P. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta-T1 bladder cancer: A metaanalysis of published results of randomized clinical trials. J Urol 2004;171: 2186–90.; Xishuang S., Deyong Y, Xiangyu C. et al. Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol 2010;24(1):69–73.; Muto G., Collura D., Giacobbe A. et al. Thulium: yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages. Urology 2014;83(4):851–5.; https://oncourology.abvpress.ru/oncur/article/view/416
-
12Academic Journal
Συγγραφείς: УЛЬЯНИН М.Ю., БАСИАШВИЛИ Г.Т., ХАСАНОВ Р.Ш., ГАТАУЛЛИН И.Г., БУРМИСТРОВ М.В., ХАЙРУЛЛИНА Г.Р.
Περιγραφή αρχείου: text/html
-
13Academic Journal
Συγγραφείς: М. Yu. Ulyanin, G. Т. Basiashvili, R. Sh. Khasanov, М. V. Burmistrov, I. G. Gataullin, М. Ю. Ульянин, Г. Т. Басиашвили, Р. Ш. Хасанов, М. В. Бурмистров, И. Г. Гатауллин
Πηγή: Siberian journal of oncology; № 5 (2015); 30-36 ; Сибирский онкологический журнал; № 5 (2015); 30-36 ; 2312-3168 ; 1814-4861 ; undefined
Θεματικοί όροι: поверхностный рак мочевого пузыря, трансуретральная резекция мочевого пузыря единым блоком, результаты лечения
Περιγραφή αρχείου: application/pdf
Relation: https://www.siboncoj.ru/jour/article/view/146/148; Державец Л.А. Лабораторные показатели и выживаемость пациентов, страдающих раком мочевого пузыря // Сибирский онкологический журнал. 2013. № 4. С. 12–16.; Злокачественные новообразования в России в 2012 г. / Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2015. 250 с.; Мартов А.Г., Ергаков Д.В., Байков Н.А., Поминальная В.М., Соломатов И.А. Трансуретральное удаление опухолей мочевого пузыря единым блоком // Онкоурология. 2015. Т. 1, № 1. С. 41–49.; Allard P., Bernard P., Fradet Y., Tetu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index // Br. J. Urol. 1998. Vol. 81 (5). P. 692–698.; Domínguez G., Carballido J., Silva J., Silva J.M., García J.M., Menéndez J., Provencio M., España P., Bonilla F. p14ARF promoter hypermetylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients // Clin. Cancer Res. 2002. Vol. 8 (4). P. 980–985.; Epstein J.I., Amin M.B., Reuter V.R., Mostofi F.K. The world health organization/international society of urological patology consensus classification of urotelial (transitional cell) neoplasms of the urinary bladder // Am. J. Surg. Pathol. 1998. Vol. 22 (12). P. 1435–1448.; Herr H.W., Donat M.S. Quality control in transurethral resection of bladder tumors // BJU Int. 2008. Vol. 102 (9. Pt. B). P. 1242–1246. doi:10.1111/j.1464-410X.2008.07966.x.; Hu Z., Mudaliar K., Quek M.L., Paner G.P., Barkan G.A. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence // Ann. Diagn. Pathol. 2014. Vol. 18 (2). P. 49–52. doi:10.1016/j.anndiagpath.2013.11.002.; Kawada T., Ebihara K., Suzuki T., Imai K., Yamanaka H. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode // J. Urol. 1997. Vol. 157 (6). P. 2225–2226.; Lodde M., Lusuardi L., Palermo S., Signorello D., Maier K., Hohenfellner R., Pycha A. En bloc transurethral resection of bladder tumors: use and limits // Urology. 2003. Vol. 62 (6). P. 1089–1091.; Millán-Rodríguez F., Chéchile-Toniolo G., Salvador-Bayarri J., Palou J., Algaba F., Vicente-Rodríguez J. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence // J. Urol. 2000. Vol. 164 (3. Pt 1.) P. 680–684.; Muto G., Collura D., Giacobbe A., D’Urso L., Muto G.L., Demarchi A., Coverlizza S., Castelli E. Thulium:yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages // J. Urology. 2014. Vol. 83 (4). P. 851–855. doi:10.1016/j.urology.2013.12.022.; Naselli A., Introini C., Germinale F., Spina B., Puppo P. En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm // BJU Int. 2012. Vol. 109 (6). P. 960–963. doi:10.1111/j.1464410X.2012.10982.x.; Saito S. Transurethral en bloc resection of bladder tumors // J. Urol. 2001. Vol. 166 (6). P. 2148–2150.; Upadhyay R., Kapoor R., Srivastava A., Krishnani N., Mandhani A. Does En-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen? // Indian J. Urol. 2012. Vol. 28 (3). P. 275–279. doi:10.4103/0970-1591.102700.; https://www.siboncoj.ru/jour/article/view/146; undefined
Διαθεσιμότητα: https://www.siboncoj.ru/jour/article/view/146
-
14Academic Journal
Συγγραφείς: М. И. Волкова, М. М. Тхакохов, В. А. Черняев, К. М. Фигурин, В. А. Романов, С. А. Калинин, М. В. Петерс, О. И. Евсюкова, В. Б. Матвеев
Συνεισφορές: нет
Πηγή: Cancer Urology; Том 12, № 4 (2016); 131-141 ; Онкоурология; Том 12, № 4 (2016); 131-141 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2016-12-4
Θεματικοί όροι: уретерогидронефроз, трансуретральная резекция, открытая резекция мочевого пузыря, мышечно-инвазивный рак мочевого пузыря, лучевая терапия, химиотерапия, радикальная цистэктомия, цистэктомия спасения, микроцистис
Περιγραφή αρχείου: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/629/614; Mak R.H., Zietman A.L., Heney N.M. et al. Bladder preservation: optimizing radiotherapy and integrated treatment strategies. BJU Int 2008;102(9 Pt B):1345–53. DOI:10.1111/j.1464-410X.2008.07981.x. PMID: 19035903.; Shipley W.U., Kaufman D.S., Zehr E. et al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 2002;60(1):62–7; discussion 67–8. PMID: 12100923.; Shipley W.U., Winter K.A., Kaufman D.S. et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89–03. J Clin Oncol 1998;16(11):3576–83. DOI:10.1200/jco.1998.16.11.3576. PMID: 9817278.; Efstathiou J.A., Bae K., Shipley W.U. et al. Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06. J Clin Oncol 2009;27(25):4055–61. DOI:10.1200/JCO.2008.19.5776. PMID: 19636019.; Eswara J.R., Efstathiou J.A., Heney N.M. et al. Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer. J Urol 2012;187(2):463–8. DOI:10.1016/j.juro.2011.09.159. PMID: 22177159.; Nieuwenhuijzen J.A., Horenblas S., Meinhardt W. Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer. BJU Int 2004;94(6):793–7. DOI:10.1111/j.1464-410X.2004.05034.x. PMID: 15476510.; Bochner B.H., Figueroa A.J., Skinner E.C. et al. Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure. J Urol 1998;160(1):29–33. PMID: 9628599.; Srikishen N., Abreu A., Aghazadeh M. Robotic salvage cystectomy is safe: multiinstitutional perioperative outcomes. AUA 2015. Abstract: PD31–04.; Gschwend J.E., May F., Paiss T. et al. High-dose pelvic irradiation followed by ileal neobladder urinary diversion: complications and long-term results. Br J Urol 1996;77(5):680–3. PMID: 8689110.; Eisenberg Dorin R.P. Bartsch G. et al. Early complications of cystectomy after high dose pelvic radiation. J Urol 2010;184(6):2264–9. DOI:10.1016/j.juro.2010.08.007. PMID: 20952024.; Ahlering T.E., Lieskovsky G., Skinner D.G. Salvage surgery plus androgen deprivation for radioresistant prostatic adenocarcinoma. J Urol 1992;147(3 Pt 2):900–2. PMID: 1538492.; Blandy J.P., England H.R., Evans S.J. et al. T3 bladder cancer – the case for salvage cystectomy. Br J Urol 1980;52(6):506–10. PMID: 7459580.; Lund F. Cystectomy following full course irradiation//in bladder tumors and other topics in urological oncology. Ettore Majorana International Science Series. Vol. 1, 1980. Pp. 287–289.; Edsmyr F., Moberger G., Wadstrom L. Carcinoma of the bladder. Cystectomy after supervoltage therapy. Scand J Urol Nephrol 1971;5(3):215–21. PMID: 4998747.; Crawford E.D., Skinner D.G. Salvage cystectomy after irradiation failure. J Urol 1980;123(1):32–4.; Swanson D.A., von Eschenbach A.C., Bracken R.B., Johnson D.E. Salvage cystectomy for bladder carcinoma. Cancer 1981;47(1):2275–9. PMID: 7226122.; Smith J.A., Whitmore W.F. Regional lymph node metastases from bladder cancer. Urol 1981;126(5):591–3. PMID: 7299915.; Abratt R.P., Wilson J.A., Pontin A.R., Barnes RD. Salvage cystectomy after radical irradiation for bladder cancer–prognostic factors and complications. Br J Urol 1993;72(5 Pt 2):756–60. PMID: 8281409.; Konnak J.W., Grossman H.B. Salvage cystectomy following failed definitive radiation therapy for transitional cell carcinoma of bladder. Urology 1985;26(6):550–3. PMID: 3934829.; Матвеев В.Б., Волкова М.И. Рак мочевого пузыря. Проблемы клинической медицины 2006;(4):10–5. [Matveev V.B., Volkova M.I. Bladder cancer. Problemy klinicheskoy meditsiny = Problems of Clinical Medicine 2006;(4):10–5. (In Russ.)].; https://oncourology.abvpress.ru/oncur/article/view/629; undefined
Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/629
-
15Academic Journal
Πηγή: Onkourologiâ, Vol 12, Iss 4, Pp 131-141 (2016)
Θεματικοί όροι: рак мочевого пузыря, трансуретральная резекция, открытая резекция мочевого пузыря, мышечно-инвазивный рак мочевого пузыря, лучевая терапия, химиотерапия, радикальная цистэктомия, цистэктомия спасения, микроцистис, уретерогидронефроз, Medicine
Relation: https://oncourology.abvpress.ru/oncur/article/view/629; https://doaj.org/toc/1726-9776; https://doaj.org/toc/1996-1812; https://doaj.org/article/5828b623d3ed46c2b5a09a822faf9c2d
Διαθεσιμότητα: https://doaj.org/article/5828b623d3ed46c2b5a09a822faf9c2d
-
16Academic Journal
Συγγραφείς: ХАЙЛЕНКО А.В., ФИГУРИН К.М., КАЗАНЦЕВ А.П., РЫБАКОВА Д.В., ПЕРЕВОЩИКОВ А.Г., РОМАНОВА К.А.
Περιγραφή αρχείου: text/html
-
17Academic Journal
Συγγραφείς: B. Ya. Alekseyev, L. О. Petrov, А. А. Krashennikov, V. V. Romikh, A. D. Kaprin, Б. Я. Алексеев, Л. О. Петров, А. А. Крашенинников, В. В. Ромих, А. Д. Каприн
Πηγή: Cancer Urology; Том 11, № 4 (2015); 96-101 ; Онкоурология; Том 11, № 4 (2015); 96-101 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2015-11-4
Θεματικοί όροι: безрецидивная выживаемость, urinary tract reconstruction, subtotal cystectomy with bladder augmentation, pelvic exenteration, resection of an anterior abdominal wall, neurological rehabilitation, botulotoxin, quality of life, progression-free survival, реконструкция мочевых путей, субтотальная резекция мочевого пузыря с аугментацией, экзентерация малого таза, резекция передней брюшной стенки, нейроурологическая реабилитация, ботулотоксин, качество жизни
Περιγραφή αρχείου: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/475/496; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/475/117; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/475/118; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/475/119; Злокачественные новообразования в России в 2013 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2015. 250 с. [Malignant neoplasms in Russia in 2013 (morbidity and mortality rate). Ed. by A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Мoscow, 2015. 250 p. (In Russ.)].; Ledermann J.A., Raja F.A. Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer. Eur J Cancer. 2011. 14. S104–S115.; Parmar M.K., Ledermann J.A., Colombo N. et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinumbased chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet 2003;14(9375):2099–106.; Pfisterer J., Vergote I., Du Bois A. et al. Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer. Int J Gynecol Cancer 2005;14(Suppl 1): 36–41.; Aghajanian C., Blank S.V., Goff B.A. et al. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol 2012;14(17):2039–45.; Bristow R.E., Puri I., Chi D.S. Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol Oncol 2009;14(1):265–74.; Van de Laar R., Zusterzeel P.L., Van Gorp T. et al. Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomized controlled study. BMC Cancer 2014;14:22 (abstr).; Fotopoulou C., Zang R., Gultekin M. et al. Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation. Ann Surg Oncol 2013;20:1348–54.; https://oncourology.abvpress.ru/oncur/article/view/475
-
18Academic Journal
Συγγραφείς: УЛЬЯНИН МИХАИЛ ЮРЬЕВИЧ, БАСИАШВИЛИ ГЕОРГИЙ ТАРИЕЛОВИЧ, ХАСАНОВ РУСТЕМ ШАМИЛЬЕВИЧ, БУРМИСТРОВ МИХАИЛ ВЛАДИМИРОВИЧ, ГАТАУЛЛИН ИЛЬГИЗ ГАБДУЛЛОВИЧ
Περιγραφή αρχείου: text/html
-
19Academic Journal
Συγγραφείς: Нюшко, Кирилл, Алексеев, Борис, Каприн, Андрей
Θεματικοί όροι: РАК УРАХУСА, КЛИНИЧЕСКИЙ СЛУЧАЙ, ХИРУРГИЧЕСКОЕ ЛЕЧЕНИЕ, РЕЗЕКЦИЯ МОЧЕВОГО ПУЗЫРЯ, РАДИКАЛЬНАЯ ЦИСТЭКТОМИЯ
Περιγραφή αρχείου: text/html
-
20Academic Journal
Συγγραφείς: АЛЕКСЕЕВ Б.Я., ПЕТРОВ Л.О., КРАШЕНИННИКОВ А.А., РОМИХ В.В., КАПРИН А.Д.
Περιγραφή αρχείου: text/html
